3Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders[J]. Surv Ophthalmol,1984,28(4):293-322.
4Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus[J]. Am J Ophthalmol,1986, 101 (3) :267-273.
5Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue[J]. Exp Eye Res,1998 ,66(1) :97-103.
6Letko E, Majmudar PA, Forstot SL, et al. UVA-light and riboflavin-mediated corneal collagen cross-linking[J]. Int Ophthalmol Clin ,2011,51 (2) :63-76.
7Greenstein SA, Shah VP, Fry KL, et al. Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results[J]. J Cataract Refract Surg, 2011,37(4) :691-700.
8Raiskup F, Spoerl E. Corneal cross-linking with hypo-osmolar riboflavin solution in thin keratoconic corneas[J]. Am J Ophthalmol,2011,152(1 ) :28-32.
9Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus[J]. Am J Ophthalmol, 2003,135 (5) : 620-627.
10Sung HW, Chang WH, Ma CY, et al. Crosslinking of biological tissues using genipin and/or carbodiimide[J]. J Biomed Mater Res A, 2003,64 (3) : 427-438.
